x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Proactive - Interviews for investors

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

business investing

All Episodes

00:02:48

Faron Pharmaceuticals CEO on benefits of Innovation...

Proactive - Interviews for investors ·

2024/12/03

Faron Pharmaceuticals Limited (AIM:FARN) CEO Dr Juho Jalkanen talked with Proactive's Stephen about the significant fast-track designation awarded to their cancer immunotherapy, bexmarilimab, by the UK's Medicines and Healthcare products Regulatory Agency (MHRA). This milestone aligns with prior FDA acknowledgments, marking critical progress in addressing relapsed refractory Myelodysplastic Syndrome (r/r MDS). Faron also announced MHRA approval to expand its BEXMAB trial to UK sites. Jalkanen

en

00:03:41

Georgina Energy CEO on next steps following Hussar...

Proactive - Interviews for investors ·

2024/12/03

Georgina Energy PLC (LSE:GEX) CEO Anthony Hamilton takes Proactive's Stephen Gunnion through the company’s advancements at the Hussar EP513 helium project. Hamilton detailed the recent site inspection, which included environmental and civil engineering studies for drill site preparation, access roads, and a potable water well. These findings will be part of Georgina Energy's drilling permit application submitted to regulators. Hamilton highlighted that the project is progressing as expected, with

en

00:03:36

Thor Explorations expands program following...

Proactive - Interviews for investors ·

2024/12/03

Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF) CEO Segun Lawson talked with Proactive's Stephen Gunnion about the company’s latest drill results at the Segilola Gold Mine in Nigeria. Lawson shared that the drilling program has revealed promising signs of high-grade gold mineralisation, extending beyond the current mine plan. “We’re very pleased with how the results have come back,” Lawson said, highlighting intersections such as 3.5 meters grading over 4 grams per tonne, located more than

en

00:07:08

Tharisa CEO on record 2024 chrome production, safety...

Proactive - Interviews for investors ·

2024/12/03

Tharisa PLC (LSE:THS, JSE:THA, OTC:TIHRF) CEO Phoevos Pouroulis talked with Proactive's Stephen Gunnion about the company's strong performance for the year to 30 September, highlighting record chrome concentrate production of 1.70 million tons at a robust price of $299 per ton, driving an 11% revenue increase to $721 million. He emphasised the company’s commitment to safety, marking a year free of lost-time injuries. Pouroulis discussed Tharisa's ongoing progress in downstream beneficiation,

en

00:04:15

ONAR Acquires VMed, Rebrands to Of Kos to Drive...

Proactive - Interviews for investors ·

2024/12/03

ONAR CEO Claude Zdanow joined Steve Darling from Proactive to share news the company has announced the acquisition and rebranding of healthcare marketing firm VMed to Of Kos, marking a strategic expansion into the healthcare sector. This move is part of ONAR’s broader vision to lead emerging markets by integrating healthcare marketing into its suite of specialized services. The acquisition, initiated in March 2023, reflects ONAR’s commitment to innovation and growth. Of Kos, formerly VMed, began by

en

00:03:46

Candel Therapeutics progresses Phase 3 trial for...

Proactive - Interviews for investors ·

2024/12/03

Candel Therapeutics Chief Medical Officer Garrett Nichols spoke with Steve Darling from Proactive to share updates on the company’s Phase 3 trial investigating an innovative therapeutic approach for patients with intermediate to high-risk localized prostate cancer. The study involves 711 participants randomized in a 2:1 ratio to receive either the experimental therapy or placebo injections, both administered alongside radiotherapy. The trial aims to achieve a 15% improvement in cure rates by

en

00:06:21

Perion Network CEO Highlights AI-Driven Innovations...

Proactive - Interviews for investors ·

2024/12/03

Perion Network CEO Tal Jacobsen joined Steve Darling from Proactive to discuss the company's forward-thinking approach to advertising technology. Leveraging AI-driven tools, Perion enables advertisers to analyze and optimize ad spend across connected TV (CTV), social media, and the open web, bridging the gap between online and offline sales for retailers and brands. Jacobsen highlighted a recent partnership with A360 Media, which equips advertisers on platforms like Us Weekly with advanced

en

00:05:42

American Rare Earths reports High-Grade assay results...

Proactive - Interviews for investors ·

2024/12/03

American Rare Earths CEO Chris Gibbs joined Steve Darling from Proactive to unveil the final assay results from the 2024 drilling campaign at the Cowboy State Mine within the Halleck Creek Project in Wyoming. These results mark a significant step in ARR’s mission to establish a world-class rare earth resource essential for bolstering U.S. critical mineral supply chains. Drilling revealed multiple high-grade intersections exceeding 5,000 ppm Total Rare Earth Oxides, highlighting the project’s

en

00:01:16

Just the Facts: Provaris targets scalable carbon...

Proactive - Interviews for investors ·

2024/12/03

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Provaris Energy Ltd (ASX:PV1, OTC:GBBLF). The company has passed a milestone in its joint development agreement with Yinson Production Offshore, receiving US$200,000 for technical services and intellectual property related to its CO2 Tank project. The collaboration, which began in October 2024, focuses on developing innovative solutions for large-scale liquid CO2 storage and transport. Provaris is adapting its proprietary

en

00:01:50

Just the Facts: St George Mining secures $3 million...

Proactive - Interviews for investors ·

2024/12/03

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from St George Mining Ltd (ASX:SGQ). The company has raised $3 million through a placement to sophisticated and institutional investors, with shares priced at $0.02. The funds will support exploration at the company’s existing projects while St George continues to finalise the acquisition of the Araxá Niobium-Rare Earth Element Project in Minas Gerais, Brazil, slated for completion in Q1 2025. The placement involves 150

en

00:01:37

Just the Facts: Predictive Discovery confirms...

Proactive - Interviews for investors ·

2024/12/03

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Predictive Discovery Ltd (ASX:PDI, OTC:PDIYF). The company, through its local company Mamou Resources, has received high-grade gold results from resource definition drilling at the 800W target of the Bankan Gold Project in Guinea. Key intersections include 5 metres at 7.98 g/t gold from 20 metres, including 2 metres at 18.73 g/t. These results expand the mineralisation northeast along strike and outside the existing

en

00:02:04

Just the Facts: Lightning Minerals pinpoints strong...

Proactive - Interviews for investors ·

2024/12/03

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Lightning Minerals Ltd (ASX:L1M). The company has identified strong lithium targets at its Caraíbas project in the Lithium Valley region of Minas Gerais, Brazil. Soil sampling assays have yielded values up to 239ppm lithium, with numerous results exceeding 100ppm, confirming a strong soil response within the Salinas Formation geological unit. The sampling program comprised 343 samples along 400-metre lines, identifying

en

00:02:01

Just the Facts: Percheron hits milestone in Duchenne...

Proactive - Interviews for investors ·

2024/12/02

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF). The company has reached a significant milestone in its Phase 2b clinical trial of avicursen (ATL-1102), a treatment for Duchenne muscular dystrophy. All 48 participants completed their week-25 visits, marking a key point in the trial focused on non-ambulant boys with advanced disease progression, a subgroup representing approximately half of the Duchenne population. Data

en

00:03:51

Energy Plug Technologies unveils Plug-and-Play...

Proactive - Interviews for investors ·

2024/12/02

Energy Plug Technologies CEO Broderick Gunning joined Steve Darling from Proactive to announce the launch of the company's latest innovation, the Off-Grid EV Charging Station, designed to bolster electric vehicle infrastructure in remote and underserved areas. This cutting-edge solution incorporates Energy Plug's advanced Battery Energy Storage System (BESS) and renewable energy technologies, offering a portable, eco-friendly alternative to traditional grid-dependent charging stations. The modular

en

00:05:59

Medicus Pharma’s Phase 2 study enrolls 25% of...

Proactive - Interviews for investors ·

2024/12/02

Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to to announce a new agreement with Swanielle to explore expanding the Phase 2 clinical study of a potential treatment for Basal Cell Carcinoma (BCC) into the Asia-Pacific region. The ongoing Phase 2 study, currently being conducted at nine clinical sites in the United States, has already enrolled over 25% of the targeted 60 patients. Medicus Pharma plans to conduct an interim analysis of the data in Q1 2025 and submit the

en

00:03:59

U.S. Gold Corp. secures $10.2M in funding and...

Proactive - Interviews for investors ·

2024/12/02

U.S. Gold Corp. CEO Geroge Bee joined Steve Darling from Proactive to share significant updates about the company's latest developments. The company announced the successful execution of a securities purchase agreement in a registered direct offering, generating gross proceeds of approximately $10.2 million. The offering includes warrants exercisable six months after issuance and expiring three years from the initial issue date. Closing is anticipated on or around December 2, 2024, subject to

en

00:03:50

Volta Metals identifies new Lithium targets at Falcon...

Proactive - Interviews for investors ·

2024/12/02

Volta Metals CEO Kerem Usenmez joined Steve Darling from Proactive to share promising results from a mobile metal ion (MMI) soil sampling program at the Falcon West Lithium Project in Northwest Ontario. The sampling, guided by high-resolution aeromagnetic and LIDAR surveys, identified five primary and five secondary targets with anomalous lithium response ratios, suggesting strong potential for lithium-bearing pegmatites. The program not only targeted lithium but also cesium, tantalum, and

en

00:04:53

Power Nickel provides exploration update on Lion Zone...

Proactive - Interviews for investors ·

2024/12/02

Power Nickel Inc CEO Terry Lynch joined Steve Darling from Proactive to share an exploration update on the Lion Zone discovery at the Nisk Project near Nemaska, Quebec. Assays to date reveal that the Lion Zone extends over a strike length of 550 meters, adjacent to an ultramafic rock unit outcropping at surface for 1.8 kilometers. The winter drill program is advancing westward from the established 550-meter strike length, with step-out drilling at 150-meter intervals. Holes 76, 78, 79, 80, and 81

en

00:04:38

First Phosphate signs technology license with Prayon:...

Proactive - Interviews for investors ·

2024/12/02

First Phosphate's CEO, John Passalacqua joined Steve Darling from Proactive to announce the company’s agreement with Prayon SA of Belgium to license its advanced technology for producing merchant-grade phosphoric acid from igneous apatite phosphate rock, alongside high-purity gypsum. The license enables First Phosphate to design, build, and operate a manufacturing facility in Canada with a production capacity of 600 metric tons of phosphoric acid per day. To support the project, First Phosphate has

en

00:07:44

Zero Candida celebrates TSX Venture listing and...

Proactive - Interviews for investors ·

2024/12/02

Zero Candida Co-Founder and CEO Eli Ben-Haroosh joined Steve Darling from Proactive to mark a significant milestone as the company opened the market in celebration of its listing on the TSX Venture Exchange under the ticker symbol ZCT. The listing highlights the company’s mission to revolutionize women’s health with its groundbreaking technology. Zero Candida’s patented innovation leverages controlled “Blue Light” technology to effectively destroy fungal infections at unprecedented speed and

en

4,496 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...